Manabtab, Samantha R.
HRN: 19-49-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
07/25/2022
08/01/2022
IV
4ml
Bid
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes